|
|
|
Potential of tailoring drugs to genetic makeup confirmed--but challenges remain
At a time when harmful drug reactions are thought to rank just after strokes as a leading cause of death in the U.S., the potential benefits of tailoring drugs to a patient’s genetic makeup have been confirmed in a systematic study led by University of California, San Francisco scientists. NIH/National Institute of Allergy and Infectious Diseases and the National Cancer Institute Contact:
Wallace Ravven
wravven@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Message posted by: Wouter Kalle
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|